Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spine Next was a French medical device company that specialized in the development of innovative spinal implants and motion-preservation technologies. The company is best known for its Wallis interspinous spacer, a dynamic stabilization system designed to treat degenerative disc disease without the need for rigid fusion. Founded in 1999 and based in Bordeaux, France, Spine Next focused on providing surgical solutions that maintain spinal mobility and reduce adjacent segment degeneration. In 2004, the company was acquired by Abbott Laboratories for approximately $60 million to expand its Abbott Spine division. The Spine Next portfolio eventually became part of Zimmer Biomet following Abbott's divestiture of its spinal business in 2008.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spine Next.